Delivery Order SPE2DB20D3505-SPE2DB25FT7E5

Award Date 1/2/25
Potential Completion Date 1/3/25
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,218.16, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty medication. The contract has an ultimate completion date of October 22, 2024 and is structured as a Firm Fixed Price Delivery Order. This award is not associated with a set-aside program. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,028.23, is a Firm Fixed Price Delivery Order for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty medication. The contract has an ultimate completion date of January 2, 2025 and was awarded on December 31, 2024. This award is part of a larger Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,047.50, is a delivery order for the supply of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a specialty medication. The contract has an ultimate completion date of January 2, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,229.82, is a Delivery Order for the medical product "WEGOVY 2.4 MG/0.75 ML PEN 0.75ML". The contract has a firm fixed price and an ultimate completion date of December 12, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award, valued at $1,923.68, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of October 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award, valued at $2,457.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of January 3, 2025. The contract is for the provision of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. This contract award is not designated as a set-aside and was competitively...
This federal contract award, valued at $14,550.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialized pharmaceutical product, with a completion date of December 2, 2024. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen holds a...
This federal contract award, valued at $5,979.47, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract provides for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a pharmaceutical product, with a completion date of December 27, 2024. This is a delivery order contract with a firm fixed price pricing type. The award is not associated with a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,644.40 firm fixed-price delivery order covers the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty medication. The contract has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,228.50, is a Delivery Order for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a prescription medication. The contract has a set completion date of December 9, 2024 and utilizes a Firm Fixed Price pricing type. This award is a part of a larger Indefinite Delivery Contract (IDC) held by...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB25FT7E5
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,473.80, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML medical supplies. The contract is a Firm Fixed Price Delivery Order with a completion date of January 3, 2025. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/3/25, 10:56 AM